The AHSN Network has supported many innovators to help advance our health and care system. Find out more about successful innovations supported by the NHS.
Find your nearest AHSN
Johnson & Johnson and Oxford AHSN cement relationship over five-year strategic partnership
The Oxford AHSN already enjoys a very productive relationship with the global healthcare company Johnson & Johnson (J&J). J&J is one of the largest employers linked to healthcare in our region with its headquarters in High Wycombe.
Engage - employee engagement app
We know that NHS staff are under a significant pressure at the moment and many managers are working at home. At a time when internal comms and employee engagement has never been more important it can be challenging to keep staff supported and updated. Now many trusts are starting to be creative about their colleague engagement. Whether you want to give staff live updates on infection prevention or information about health and wellbeing initiatives in the Trust, our app can help.
FeNO testing for suspected asthma patients
FeNO (Fractional exhaled Nitric Oxide) testing alongside the recommended NICE diagnostic tests, will help enable more accurate diagnosis of asthma. Over 120,000 patients a year, 30% of the asthma population, are wrongly diagnosed and given inappropriate medication. Our project will look to reduce the use of steroids and improve diagnosis, enabling correct adjustments or the right medication to be prescribed. FeNO is indicative of the severity of airway inflammation.
Asthma Biologic precision medicines for the treatment of severe eosinophilic asthma
Less than 50% of severe asthma patients have eosinophil-driven disease (Wenzel2005) and Biologics are designed to control the number of eosinophil cells (Asthma UK). Only 10.8% of eligible severe asthma patients have access to biologic medicines today in the UK.Increasing the use of biologics appropriately would reduce use of Oral corticosteroids (OCS), associated with negative side effects, and exacerbations, causing 75,000 annual UK hospital admissions, each costing £1500.
Preventing prescribing errors in south London with PINCER
PINCER is the Pharmacist-led Information technology iNtervention for the reduction of Clinically important ERrors in medicines management.
High-sensitivity troponin tests for the early rule out of non-ST-segment elevation myocardial infarction (NSTEMI)
The improved accuracy of the high sensitivity test compared to the standard troponin test allows testing of troponin concentration and type (T or I) at 1-hour and/or 3-hours post ED presentation. This innovation adoption in both technology and pathway will greatly improve patient care and efficiency at ED, enabling patients to be sent home secure in the knowledge that a heart attack has not occurred while keeping beds free in ED.
Cladribine for treating relapsing–remitting multiple sclerosis
The UK multiple sclerosis (MS) population is expected to increase annually by 2.4%1. Cladribine offers an orally administered option for highly active relapsing-remitting MS, avoiding the need for infusions, and requires less frequent dosing and monitoring compared to other therapies.
Active+me is a solution developed by Aseptika which empowers patients to take charge of their own recovery, providing them with standard cardiac rehabilitation care which includes guidance on safe exercise and education on risk factors and lifestyle changes, reinforced by educational resources on the Active+me platform. In addition, patients are provided with medical monitors to take home and record progress such as activity levels, blood pressure, weight and oxygen saturation. The data from which are uploaded to an app and shared securely with the hospital’s cardiac rehabilitation team. In response to the Coronavirus pandemic, Aseptika adapted the programme to help patients keep up their exercise remotely and manage their recovery thanks to funding from Innovate UK and support from Eastern AHSN. Active+me REMOTE
CamAPS FX is an artificial pancreas app which aims to help manage glucose levels in people with type 1 diabetes, aged one year and older, using a hybrid closed-loop approach. The user has the option of easing off or boosting therapy as physiological demands require, such as during exercise. The app runs on a standard Android smartphone and feeds data to the cloud so that health care professionals and loved ones including parents can see their children’s levels at any time on their phones. Developed by CamDiab at the University of Cambridge trials have shown a significant increase in glucose time in range and improved quality of life, as well as a reduction in time spent in hypoglycaemia and hyperglycaemia. An Eastern AHSN commissioned health economic assessment also demonstrated a potential cost saving of £3.2m per year for healthcare in the UK. We are now supporting the roll out of this innovation across the NHS. Visit the CamDiab website now.
Self Cleaning Alcohol Gel Door Push Pads; Pull Handles, Kill Germs in SECONDS
Multiple Individuals can pass through a door only SECONDS apart. Surfaceskins Alcohol Gel Door Push Pads & Pull Handles are engineered by infection control experts to KILL germs in SECONDS & protect EVERY door user. Over 5 years of development & validation in NHS Laboratories, hospital & schools to help provide ultimate touch protection with two studies in the JOHI [Journal of Hospital Infection]. For more information please visit www.surfaceskins.com Or email: email@example.com or firstname.lastname@example.org
Covid Oximetry @home and virtual ward
The HIN has been commissioned to support a drive to equip members and partners to offer the Covid Oximetry @home model. This comes as treatment of Covid-19 improves and evidence has shown that earlier detection of (silent) hypoxia at home could help further reduce mortality and morbidity.
WorkPAL - digital performance empowerment tool
WorkPAL is our flagship digital performance empowerment platform. We use cloud technology to provide modern and secure tools for HR and OD professionals, NHS managers and executives to provide real-time data and reporting on workforce performance and productivity. We provide timely, consistent data and a robust audit trail about how staff are working to achieve organisational objectives, and who is working within the leadership narrative of values, behaviours, goals.